Johnson & Johnson (NYSE: JNJ)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Johnson & Johnson (NYSE: JNJ) through any online brokerage.
Other companies in Johnson & Johnson’s space includes: Novo Nordisk (NYSE:NVO), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS), Roivant Sciences (NASDAQ:ROIV) and Pfizer (NYSE:PFE).
The latest price target for Johnson & Johnson (NYSE: JNJ) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting JNJ to fall to within 12 months (a possible -97.58% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Johnson & Johnson (NYSE: JNJ) is $165.3 last updated August 12, 2022, 7:59 PM UTC.
The next Johnson & Johnson (JNJ) dividend date is projected to be Thursday, September 1, 2022.
Johnson & Johnson’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Johnson & Johnson.
Johnson & Johnson is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.